RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia–induced pulmonary arterial hypertension in rats

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia–induced pulmonary arterial hypertension in rats
Authors
Keywords
Anti-proliferative agent, RP5063, 5-hydroxytryptamine 2B receptor, Pulmonary arterial hypertension, Rat Sugen 5416-hypoxia model, Vascular remodeling
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 810, Issue -, Pages 83-91
Publisher
Elsevier BV
Online
2017-06-01
DOI
10.1016/j.ejphar.2017.05.052

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.